Nesplora

About:

Nesplora develops software tools in virtual reality environments for the evaluation of various neurological pathologies.

Website: http://nesplora.com/

Twitter/X: nesplora

Top Investors: EASME - EU Executive Agency for SMEs

Description:

Nesplora develops software tools in virtual reality environments for the evaluation of various neurological pathologies. It offers a disruptive conception of evaluating human cognition and behavior using standardized and scientifically validated virtual reality scenarios. The company has revolutionized the evaluation of behavior and cognition, making it more scientific, functional and objective. Nesplora has received EU funding from Phase 1 and 2 of Horizon 2020’s SME Instrument. Nesplora products are scientific tests, all scaled, contrasted and validated. Currently, these measurements are made with pencil and paper, with pseudo-objective tests or with subjective questionnaires to the family or the patient. They design and develop innovative tools to improve the diagnosis of patients with such far-reaching and universal problems as Alzheimer's, mental illness, brain damage of any etiology or developmental problems.

Total Funding Amount:

1.46M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Donostia-san Sebastián, Pais Vasco, Spain

Founded Date:

2009-01-01

Contact Email:

info(AT)nesplora.com

Founders:

Gema Climent

Number of Employees:

11-50

Last Funding Date:

2017-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai